Pharmacoeconomic evaluation of baritinib in the treatment of adult patient with moderate to severe rheumatoid arthritis with intolerance or lack of an adequate response to treatment with one or more basic antirheumatic drugs in the Russian Federation
Keyword(s):
Keyword(s):
2015 ◽
Vol 53
(5)
◽
pp. 472-484
◽
Keyword(s):
2013 ◽
Vol 73
(1)
◽
pp. 69-74
◽
2014 ◽
Vol 73
(Suppl 2)
◽
pp. 1133.3-1134